Conduit Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CDT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
07 Oct 24	SellUS$393,439	Nirland Limited	Company	38,080	US$10.43
02 Oct 24	SellUS$297,644	Nirland Limited	Company	26,000	US$12.00
17 Jul 24	SellUS$4,249,062	Corvus Capital	Company	139,112.48	US$64.00
12 Jul 24	SellUS$343,425	Corvus Capital	Company	13,898.2	US$24.71

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CDT?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	73,892	0.652%
Individual Insiders	139,867	1.23%
Institutions	869,026	7.66%
Private Companies	1,853,933	16.4%
General Public	8,401,805	74.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1520.1%.

Top Shareholders

Top 25 shareholders own 25.8% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.4%	SARBORG Limited	1,853,933	US$762.8k	0%	no data
2.67%	Corvus Capital	302,260	US$124.4k	0%	no data
1.06%	AQR Capital Management, LLC	120,743	US$49.7k	9,900%	no data
0.98%	State Street Global Advisors, Inc.	110,910	US$45.6k	12,700%	no data
0.7%	UBS Asset Management AG	79,714	US$32.8k	26,700%	no data
0.65%	AstraZeneca PLC	73,892	US$30.4k	-22.3%	no data
0.63%	Freda Lewis-Hall	71,938	US$29.6k	-6.81%	no data
0.35%	Presidio Property Trust, Inc.	40,153	US$16.5k	0%	100.0%
0.31%	Chele Farley	35,537	US$14.6k	0%	no data
0.28%	Simon Fry	31,354	US$12.9k	0%	no data
0.27%	Vanguard Personalized Indexing Management	30,382	US$12.5k	5,240%	no data
0.2%	Squarepoint OPS LLC	22,927	US$9.4k	0%	no data
0.18%	IFP Advisors, LLC	20,000	US$8.2k	0%	no data
0.17%	Susquehanna International Group, LLP, Asset Management Arm	19,276	US$7.9k	7,610%	no data
0.16%	Geode Capital Management, LLC	18,637	US$7.7k	219%	no data
0.15%	FMR LLC	17,152	US$7.1k	904%	no data
0.11%	Goldman Sachs Asset Management, L.P.	12,575	US$5.2k	871%	no data
0.1%	IEQ Capital, LLC	11,610	US$4.8k	0%	no data
0.096%	Russell Investment Management, LLC	10,889	US$4.5k	0%	no data
0.091%	Eaton Vance Management	10,276	US$4.2k	46,600%	no data
0.079%	Carson Wealth Management Group	8,957	US$3.7k	128,000%	no data
0.078%	Barclays PLC Private Banking & Investment Banking Investment	8,838	US$3.6k	-0.95%	no data
0.054%	Rhumbline Advisers Ltd Partnership	6,177	US$2.5k	-40%	no data
0.038%	BlackRock, Inc.	4,334	US$1.8k	-19.7%	no data
0.026%	Tower Research Capital Europe Limited	2,987	US$1.2k	246%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/18 12:50
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Conduit Pharmaceuticals Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.